Market Value1,785,149,209
Total Holdings64
File Date2023-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
HARP / Harpoon Therapeutics, Inc.
AXNX / Axonics, Inc.
IDYA / IDEAYA Biosciences, Inc.
VRDN / Viridian Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
AKRO / Akero Therapeutics, Inc.
OLMA / Olema Pharmaceuticals, Inc.
LPTX / Leap Therapeutics, Inc.
RAIN / Rain Enhancement Technologies Holdco, Inc.
CABA / Cabaletta Bio, Inc.
CMMB / Chemomab Therapeutics Ltd. - Depositary Receipt (Common Stock)
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
PRME / Prime Medicine, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
APLS / Apellis Pharmaceuticals, Inc.
AVIR / Atea Pharmaceuticals, Inc.
PYXS / Pyxis Oncology, Inc.
CYTK / Cytokinetics, Incorporated
ANNX / Annexon, Inc.
ALXO / ALX Oncology Holdings Inc.
ICVX / Icosavax, Inc.
OCUL / Ocular Therapeutix, Inc.
XFOR / X4 Pharmaceuticals, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
DSGN / Design Therapeutics, Inc.
RXDX / Prometheus Biosciences Inc
RCKT / Rocket Pharmaceuticals, Inc.
FULC / Fulcrum Therapeutics, Inc.
IMVT / Immunovant, Inc.
VIGL / Vigil Neuroscience, Inc.
AVTE / Aerovate Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AXSM / Axsome Therapeutics, Inc.
VECT / VectivBio Holding AG
LBPH / Longboard Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
TNGX / Tango Therapeutics, Inc.
PSTX / Poseida Therapeutics, Inc.
US39536G1058 / GREENLIGHT BIOSCIENCES HOLDINGS PBC A
PTGX / Protagonist Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc. Put
BBIO / BridgeBio Pharma, Inc.
PHVS / Pharvaris N.V.
PCVX / Vaxcyte, Inc.
RNA / Avidity Biosciences, Inc.
PRAX / Praxis Precision Medicines, Inc.
GHRS / GH Research PLC
GLUE / Monte Rosa Therapeutics, Inc.
ISEE / IVERIC bio Inc Call
RAPT / RAPT Therapeutics, Inc.
GRPH / Graphite Bio, Inc.
IMRX / Immuneering Corporation
VKTX / Viking Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
ERAS / Erasca, Inc.
ELEV / Elevation Oncology, Inc.
SRPT / Sarepta Therapeutics, Inc.
BCEL / Atreca, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
GLTO / Galecto, Inc.
ETNB / 89bio, Inc.
COGT / Cogent Biosciences, Inc.
MORF / Morphic Holding, Inc.
ELVN / Enliven Therapeutics, Inc.
LIANY / LianBio - Depositary Receipt (Common Stock)
KRTX / Karuna Therapeutics, Inc.
TALS / Talaris Therapeutics Inc
IRON / Disc Medicine, Inc.
BCAB / BioAtla, Inc.
BMEA / Biomea Fusion, Inc.
BHVN / Biohaven Ltd.
AMAM / Ambrx Biopharma Inc.
MLTX / MoonLake Immunotherapeutics
ACLX / Arcellx, Inc.
VERV / Verve Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
EYPT / EyePoint Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc. Call